Open AccessBody mass index increase in preschoolers with heterogeneous psychiatric diagnoses treated with risperidone
Author(s) -
Matan Avrahami,
Miriam Peskin,
Tyler M. Moore,
Adi Drapisz,
Jerome Taylor,
Hadar Segal-Gavish,
Livia Balan-Moshe,
Issac Shachar,
Tomer Levy,
Abraham Weizman,
Ran Barzilay
Publication year - 2021
Publication title -
journal of psychopharmacology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.333
H-Index - 114
eISSN - 1461-7285
pISSN - 0269-8811
DOI - 10.1177/02698811211008592
Subject(s) - risperidone , psychiatry , body mass index , psychology , medical diagnosis , psychiatric diagnosis , medicine , clinical psychology , schizophrenia (object oriented programming) , pathology
Use of risperidone in preschool-aged children is growing, with rising concerns of adverse metabolic consequences. Longitudinal data on risperidone-related weight gain in preschoolers are scarce. We aimed to evaluate changes in body mass index (BMI) that are associated with risperidone treatment in preschoolers.